A federal lawsuit is targeting a new Oklahoma law that puts conditions on how much drug manufacturers can charge when selling ...

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs for millions of people.

The Semaglutide market is projected to expand from US$ 27.15 billion in 2024 to US$ 61.7 billion by 2033, with a CAGR of 9.55% from 2025. Driven by r ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and ...

Game-changing diabetes pills could hit Australian shelves within years, after the first phase three clinical trial data was ...

The United Kingdom's health regulator is investigating weight loss jabs like Ozempic and Mounjaro after linking it to ...

Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. While Novo lost share to Eli Lilly's once-weekly Trulicity, Ozempic and Rybelsus ...

As threats like mites become more resistant to pesticides, California honey bees need more human intervention to save their hives.

Obesity remains one of the most pressing, and preventable, health challenges of our time. The UK is one of a number of ...

Amanda Bynes has explained in a new social media post why she's decided to start taking Ozempic. Those whose childhoods were the 1990s and early 2000s will instantly recognise Bynes as the star of ...

Former child actor Amanda Bynes on Monday shared her decision to go on Ozempic on Instagram. She expressed that she wants to lose weight to look better in paparazzi pictures.